ESCAPE

Evaluation of a patient-centred biopsychosocial blended collaborative care pathway for the treatment of multi-morbid elderly patients

Abstract

ESCAPE will rethink current practice for treating multimorbidity in elderly patients and break down health care silos that impede integrated care and lead to adverse outcomes. We will coordinate and optimise care, prioritising integration of treatment for mental distress and disorders in the treatment of multimorbidity. Our interdisciplinary multinational consortium of experts from general and hospital medical practice and psychology, health economics, ICT development and social innovation as well as patient and informal carer representatives, will develop a holistic, patient-centred intervention based on the blended collaborative care (BCC) approach and enhanced by cutting-edge information and communication technologies. Trained Care Managers will work closely together with the patient’s general practitioner under supervision of a Clinical Specialist Team. They will use a meta-algorithm integrated in the interactive imergo® e-health Integrated Care Platform to customise patients’ treatment to their individual needs and preferences and liaise among providers. The platform will also empower patients and informal carers to increase their intrinsic capacities. ESCAPE as a social innovation will decrease disease burden for patients, informal carers and ultimately society and improve their quality of life (QoL), prioritised as the most important treatment outcome by patients, carers, and multimorbidity guidelines. ESCAPE will conduct for the first time a randomised controlled trial embedded in a comprehensive cohort study design to compare BCC and usual care. We will include patients with heart failure, ≥2 medical comorbidities and psychological distress. The primary effectiveness endpoint will be patients’ health-related QoL. Medical outcomes, cost-effectiveness, and several other patient-relevant outcomes will be secondary endpoints. We will apply an active dissemination and exploitation strategy to derive maximum impact from the new pathway for multimorbidity care.

Project details

Unibo Team Leader: Chiara Rafanelli

Unibo involved Department/s:
Dipartimento di Psicologia "Renzo Canestrari"

Coordinator:
Syddansk Universitet(Denmark)

Other Participants:
Semmelweis Egyptem - Semmelweis University (Hungary)
Bundesarbeitsgemeinschaft Selbsthilfe Von Menschen Mit Behinderung Und Chronischer Erkrankung Und Ihren Angehorigen E.V. (Germany)
Intrigo Limited (Ireland)
LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS-Lithuanian University of Health Sciences (Lithuania)
Eurocarers-Association Europeenne Travaillant Avec Et Pour Les Aidants Non-Professionnels (Belgium)
Region Sjaelland (Denmark)
Universitaetsklinikum Hamburg-Eppendorf (Germany)
Universitaet Zu Koeln (Germany)
Georg-August-Universitat Gottingen Stiftung Offentlichen Rechts (Germany)
Royal College Of Surgeons In Ireland (Ireland)
Linkopings Universitet (Sweden)
ALMA MATER STUDIORUM - Università di Bologna (Italy)
Azienda Usl Di Bologna (Italy)
Fraunhofer Ipa (Germany)
Universität Leipzig (Germany)

Total Eu Contribution: Euro (EUR) 6.101.206,20
Project Duration in months: 54
Start Date: 01/04/2021
End Date: 30/09/2025

Cordis webpage

Good health and well-being This project contributes to the achievement of the Sustainable Development Goals of the UN 2030 Agenda.

UE flag This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 945377